Kabicilas 500Mg Inj

Kabicilas 500Mg Inj is used to treat severe bacterial infections of the lungs, heart, bladder, skin, kidneys, bones, joints, blood, stomach and female reproductive organs. Kabicilas 500Mg Inj may also be used in the management of patients with low white blood cell count who have a fever, which is suspected to be due to bacterial infection. Bacterial infections are caused due to the multiplication of harmful bacteria inside or on the body. Kabicilas 500Mg Inj does not work against infections caused by the virus, including cold and flu. 
 
Kabicilas 500Mg Inj is a combination of two drugs, namely: Cilastatin (dehydropeptidase inhibitor) and Imipenem (antibacterial). Cilastatin inhibits the dehydropeptidase enzyme, which causes the breakdown of Imipenem, thereby helps imipenem to stay active for a longer duration. Imipenem prevents the formation of the bacterial protective covering, which is necessary for the survival of the bacteria. Together, Kabicilas 500Mg Inj helps to treat bacterial infections.
 
Kabicilas 500Mg Inj will be administered by a healthcare professional; do not self-administer. In some cases, Kabicilas 500Mg Inj may cause common side effects such as nausea, vomiting, diarrhoea, swelling, and redness at the site of injection. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Consult your doctor if you are pregnant or breastfeeding. Kabicilas 500Mg Inj may cause dizziness, so drive with caution. Avoid alcohol consumption as it might cause increased dizziness and sleepiness. Kabicilas 500Mg Inj should not be given to children below one year or those who weigh below 30kg with kidney problems. Kabicilas 500Mg Inj is not recommended in paediatric patients with CNS infections due to the risk of seizures. Keep your doctor informed about your health condition and medications to rule out any unpleasant side effects.

Kabicilas 500Mg Inj is a combination of two drugs, namely: Cilastatin (dehydropeptidase inhibitor) and Imipenem (antibacterial). Kabicilas 500Mg Inj is used to treat severe bacterial infections of the lungs, heart, bladder, skin, kidneys, bones, joints, blood, stomach, and female reproductive organs. Kabicilas 500Mg Inj may also be used in the management of patients with low white blood cell count who have a fever, which is suspected to be due to bacterial infection. Cilastatin inhibits the dehydropeptidase enzyme, which causes the breakdown of Imipenem, thereby helps imipenem to stay active for a longer duration. Imipenem prevents the formation of the bacterial protective covering, which is necessary for the survival of the bacteria. Together, Kabicilas 500Mg Inj helps to treat bacterial infections. Imipenem is a broad-spectrum antibiotic that is effective against a wide range of aerobic and anaerobic bacteria.

Do not take Kabicilas 500Mg Inj if you are allergic to any of its components. Inform your doctor if you have an allergy to antibiotics, colitis, gastrointestinal disease, urinary/kidney problems, CNS disorders, seizures/fits, or liver problems. Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption as it might cause increased dizziness and sleepiness. Kabicilas 500Mg Inj should not be given to children below one year or those who weigh below 30kg with kidney problems. Kabicilas 500Mg Inj is not recommended in paediatric patients with CNS infections due to the risk of seizures. Kabicilas 500Mg Inj may cause dizziness and sleepiness, so drive with caution.

• Kabicilas 500Mg Inj may cause abnormal Coombs, liver, blood, and kidney function tests. Inform the person doing the tests that you are on treatment with Kabicilas 500Mg Inj.